Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Erectile Dysfunction
Trial Information
Erectile Dysfunction
This is a Phase 3 randomized, double-blind placebo controlled study to evaluate the safety and efficacy a study drug in treatment of ED in patients with diabetes. The study consists of 16 weeks with 5 office visits. You will be compensated for your time and travel upon completion of study.
Patient Inclusion Criteria
- Male 18 and older
- Have diabetes I or II, use of antidiabetic medications
- 6 month history of mild to sever ED
- Must be in a monogamous, heterosexual relationship for at least 3 months.
Patient Inclusion Criteria
- Previous or current antiandrogen therapy
- Untreated hypogonadism or testosterone <325
- Uncontrolled hypertension
- MI, Stroke, within the past 6 months
- Positive STD, HIV, or HVC
- Participation in another investicagational study within 30 days
Lisa Dunham, Recruiting
Renstar Medical Research
104 SE 1ST Ave #B
Ocala, FL 34471
Phone: 352-629-5800
View Google Map
Research Center Information: Renstar Medical Research
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
